Vitality Watch

⚠ Evidence note: Nutrition evidence is dominated by observational data with heavy confounding; trial endpoints are mostly surrogates, not lifespan.

Mentioned 1× · first seen 05-oct-2026 · last seen 05-oct-2026

Low-Methoxy Pectin in Frailty

Current understanding

A small 4-week double-blind RCT (n=29 completers) in frail older adults reported that low-methoxy (LM) pectin supplementation improved 30-second sit-to-stand performance, HADS anxiety/depression scores, and several SF-36 quality-of-life domains, alongside an increase in gut Coprococcus comes, while circulating inflammatory biomarkers were unchanged [human-rct]. The signal is preliminary — short duration, small sample, surrogate and functional endpoints rather than frailty transitions or mortality — and sits within the broader soluble-fibre/SCFA hypothesis for the gut-muscle axis [mechanism-plausible].

Evidence log

Open questions

Related

Contributing findings

pubmed trial early
The effect of pectin supplementation on geriatric individuals with frailty: a randomised placebo-controlled dietary intervention study.
28-sep-2026 novelty 3 per-area 3 introduces

build build 880 · 2bcef25 · 2026-11-18